Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

Ruiz-Irastorza, G; Cuadrado, MJ; Ruiz-Arruza, I; Brey, R; Crowther, M; Derksen, R; Erkan, D; Krilis, S; Machin, S; Pengo, V; Pierangeli, S; Tektonidou, M; Khamashta, M

dc.contributor.author	Ruiz-Irastorza, G	en
dc.contributor.author	Cuadrado, MJ	en
dc.contributor.author	Ruiz-Arruza, I	en
dc.contributor.author	Brey, R	en
dc.contributor.author	Crowther, M	en
dc.contributor.author	Derksen, R	en
dc.contributor.author	Erkan, D	en
dc.contributor.author	Krilis, S	en
dc.contributor.author	Machin, S	en
dc.contributor.author	Pengo, V	en
dc.contributor.author	Pierangeli, S	en
dc.contributor.author	Tektonidou, M	en
dc.contributor.author	Khamashta, M	en
dc.date.accessioned	2014-03-01T02:04:28Z
dc.date.available	2014-03-01T02:04:28Z
dc.date.issued	2011	en
dc.identifier.issn	0961-2033	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/29440
dc.subject	anticardiolipin	en
dc.subject	antiphospholipid	en
dc.subject	aspirin	en
dc.subject	hydroxychloroquine	en
dc.subject	lupus anticoagulant	en
dc.subject	prevention	en
dc.subject	stroke	en
dc.subject	thrombosis	en
dc.subject	warfarin	en
dc.subject.classification	Rheumatology	en
dc.subject.other	SYSTEMIC-LUPUS-ERYTHEMATOSUS	en
dc.subject.other	RISK-FACTORS	en
dc.subject.other	ANTICARDIOLIPIN ANTIBODIES	en
dc.subject.other	ISCHEMIC-STROKE	en
dc.subject.other	VENOUS THROMBOEMBOLISM	en
dc.subject.other	ANTITHROMBOTIC THERAPY	en
dc.subject.other	ANTICOAGULANT-THERAPY	en
dc.subject.other	PHOSPHOLIPID SYNDROME	en
dc.subject.other	RECURRENT THROMBOSIS	en
dc.subject.other	CLINICAL-OUTCOMES	en
dc.title	Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies	en
heal.type	journalArticle	en
heal.language	English	en
heal.publicationDate	2011	en
heal.abstract	The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-beta 2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is the result of an effort to produce guidelines for therapy within a group of specialist physicians in Cardiology, Neurology, Hematology, Rheumatology and Internal Medicine, with a clinical and research focus on APS. Lupus (2011) 20, 206-218.	en
heal.publisher	SAGE PUBLICATIONS LTD	en
heal.journalName	LUPUS	en
dc.identifier.isi	ISI:000287078600014	en
dc.identifier.volume	20	en
dc.identifier.issue	2	en
dc.identifier.spage	206	en
dc.identifier.epage	218	en